2015 American Transplant Congress » Concurrent Session: Kidney: Induction

4:00pm-4:12pm

Thymoglobulin Versus IL2RA: Three Year Results of a Randomized Controlled Trial

N. Pilch, H. Meadows, D. Taber, J. Fleming, C. Mardis, S. Nadig, J. McGillicuddy, T. Srinivas, C. Bratton, P. Baliga, K. Chavin.

4:12pm-4:24pm

Impact of Induction Therapy on Outcomes in HIV + Renal Transplant Recipients

C. Kershaw,¹ C. Rogers,^2,4 M. Pavlakis,^1,2 H. Tang,² C. Alonso,^1,2 K. Khwaja,^2,3 A. Evenson,^2,3 K. Raven,^2,3 M. Wong.^1,2

4:24pm-4:36pm

Induction Therapy Improves 15-Year Graft Survival in Kidney Transplant Recipients With Acute Rejection

R. Bajoka, M. Goggins, A. Patel.

4:36pm-4:48pm

Risk Stratification in Tailoring Induction Therapy in Kidney Transplant Recipients(KTR): Is It Cost-Effective?

B. Sirandas, A. Carlson, N. Kenyon, C. Truax, L. Smith.

4:48pm-5:00pm

Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era

B. Tanriover,¹ S. Zhang,² M. MacConmara.³

5:00pm-5:12pm

Alemtuzumab Induction Has Been Safe in the United Kingdom and Achieves Long-Term Steroid Avoidance in More Than 80% of Low Risk Renal Transplant Recipients

A. Seitz,¹ M. Robb,³ S. Balasubramanian,¹ A. McLean,² D. Taube,² R. Johnson,³ R. Baker.¹

5:12pm-5:24pm

Effectiveness of Protocol-Driven Induction Therapy in Adult Kidney Transplant Recipients

J. Casale, J. Fleming, D. Taber, C. Staino, K. Boyle, K. Covert, N. Pilch, H. Meadows, C. Mardis, K. Chavin, C. Bratton, J. McGillicuddy, T. Srinivas, P. Baliga.